Determination of Staphylococcus aureus carriage in hemodialysis and peritoneal dialysis patients and evaluation of the clonal relationship between carriage and clinical isolates

American Journal of Infection Control

Volumn 39, Issue 5, 2011, Pages 421-425

  Aktaş, Elif ^a   Pazarli, Oya ^a   Külah, Canan ^a   Cömert, Füsun ^a   Külah, Eyüp ^a   Sümbüloǧlu, Vildan ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

carrier; PFGE; renal failure; Staphylococci

Indexed keywords

ADULT; ARTICLE; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PERITONEAL DIALYSIS; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

CARRIER STATE; CROSS INFECTION; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENETIC HETEROGENEITY; GENOME, BACTERIAL; HEALTH PERSONNEL; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PATIENTS; PERITONEAL DIALYSIS; PHYLOGENY; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 79957924752     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.06.012     Document Type: Article

References (16)

1. Arduino MJ, Tokars JI. Why is an infection control program needed in the hemodialysis setting? Nephrol News Issues 2005;19:46-9.
2. Szeto CC, Chow KM, Ching-Ha Kwan B, Law MC, Chung KY, Yu S, et al. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol 2007;2:245-51.
3. Centers for Disease Control and Prevention. Invasive methicillin- resistant Staphylococcus aureus infections among dialysis patients - United States, 2005. MMWR Morb Mortal Wkly Rep 2007;56: 197-9.
4. Nouwen J, Schouten J, Schneebergen P, Snijders S, Maaskant J, Koolen M, et al. Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J Clin Microbiol 2006; 44:2233-6.
5. Lu PL, Tsai JC, Chiu YW, Chang FY, Chen YW, Hsiao CF, et al. Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 2008;23:1659-65.
6. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of meticillin-resistant Staphylococcus aureus: prevalence, patients at risk, and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res 2007;26:284-8.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
8. Elliot JA, Farmer KD, Facklam RR. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol 1998;36:2115-6.
9. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
10. Pérez FM, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005;25:274-84.
11. Altiparmak MR, Güngör K, Pamuk GE, Pamuk ON, Ozgenç R, Oztürk R. Temporary catheter infections in hemodialysis patients: results from a single center in Turkey. Acta Clin Belg 2003;58:345-9.
12. Duran N, Ocak S, Eskiocak AF. Staphylococcus aureus nasal carriage among diabetic and nondiabetic haemodialysis patients. Int J Clin Pract 2006;60:1204-9.
13. Bogut A, Kozioł-Montewka M, Baranowicz I, Jóźwiak L, Ksiazek A, Al-Doori Z, et al. Characterisation of Staphylococcus aureus nasal and skin carriage among patients undergoing haemodialysis treatment. New Microbiol 2007;30:149-54.
14. Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005;26:534-9.
15. Uttley L, Vardhan A, Mahajan S, Smart B, Hutchison A, Gokal R. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site. J Nephrol 2004;17:242-5.
16. Cavdar C, Atay T, Zeybel M, Celik A, Ozder A, Yildiz S, et al. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2004;20:67-70.